Macquarie Group’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,369
| Closed | -$2.1M | – | 1658 |
|
|
2023
Q1 | $2.1M | Sell |
25,369
-189,046
| -88% | -$17.8M | ﹤0.01% | 1151 |
|
|
2022
Q4 | $22M | Sell |
214,415
-17,201
| -7% | -$1.98M | 0.03% | 671 |
|
|
2022
Q3 | $24.6M | Sell |
231,616
-31,461
| -12% | -$3.45M | 0.03% | 636 |
|
|
2022
Q2 | $28.9M | Sell |
263,077
-317,651
| -55% | -$31.4M | 0.03% | 615 |
|
|
2022
Q1 | $60.6K | Sell |
580,728
-8,299
| -1% | -$862K | 0.05% | 456 |
|
|
2021
Q4 | $72.1M | Sell |
589,027
-10,148
| -2% | -$1.13M | 0.06% | 408 |
|
|
2021
Q3 | $68.8M | Sell |
599,175
-105,041
| -15% | -$11.1M | 0.06% | 429 |
|
|
2021
Q2 | $68.3M | Buy |
704,216
+665,185
| +1,704% | +$57.7M | 0.06% | 428 |
|
|
2021
Q1 | $2.88M | Buy |
39,031
+4,876
| +14% | +$362K | ﹤0.01% | 1070 |
|
|
2020
Q4 | $2.33M | Sell |
34,155
-2,505
| -7% | -$163K | ﹤0.01% | 1064 |
|
|
2020
Q3 | $2.14M | Buy |
36,660
+3,867
| +12% | +$204K | ﹤0.01% | 1015 |
|
|
2020
Q2 | $1.48M | Sell |
32,793
-1,774
| -5% | -$84.9K | ﹤0.01% | 1104 |
|
|
2020
Q1 | $2M | Sell |
34,567
-10,643
| -24% | -$728K | ﹤0.01% | 907 |
|
|
2019
Q4 | $2.82M | Buy |
45,210
+1,913
| +4% | +$113K | ﹤0.01% | 946 |
|
|
2019
Q3 | $2.49M | Buy |
43,297
+2,801
| +7% | +$155K | ﹤0.01% | 968 |
|
|
2019
Q2 | $2.2M | Buy |
40,496
+5,077
| +14% | +$258K | ﹤0.01% | 992 |
|
|
2019
Q1 | $1.67M | Sell |
35,419
-208,295
| -85% | -$11.5M | ﹤0.01% | 1043 |
|
|
2018
Q4 | $13.8M | Sell |
243,714
-76,435
| -24% | -$4.29M | 0.03% | 527 |
|
|
2018
Q3 | $17.5M | Sell |
320,149
-283,260
| -47% | -$16.2M | 0.03% | 514 |
|
|
2018
Q2 | $35.4M | Sell |
603,409
-6,615
| -1% | -$395K | 0.06% | 344 |
|
|
2018
Q1 | $34.6M | Sell |
610,024
-87,122
| -12% | -$4.74M | 0.06% | 331 |
|
|
2017
Q4 | $34.3M | Sell |
697,146
-81,221
| -10% | -$3.7M | 0.06% | 329 |
|
|
2017
Q3 | $35.6M | Sell |
778,367
-182,289
| -19% | -$6.97M | 0.06% | 311 |
|
|
2017
Q2 | $37.5M | Buy |
960,656
+309,693
| +48% | +$11.9M | 0.07% | 269 |
|
|
2017
Q1 | $26.4M | Buy |
650,963
+574,705
| +754% | +$22.5M | 0.05% | 383 |
|
|
2016
Q4 | $2.93M | Buy |
76,258
+517
| +0.7% | +$17.7K | 0.01% | 862 |
|
|
2016
Q3 | $2.41M | Sell |
75,741
-40,759
| -35% | -$1.55M | ﹤0.01% | 904 |
|
|
2016
Q2 | $4.66M | Buy |
116,500
+8,802
| +8% | +$326K | ﹤0.01% | 891 |
|
|
2016
Q1 | $3.62M | Buy |
+107,698
| New | +$3.08M | 0.01% | 786 |
|
Other funds holding AMN
Macquarie Group's AMN Position: Q2 2023 in Review
Macquarie Group sold out of AMN Healthcare (AMN) in Q2 2023, closing a stake of 25,369 shares — an estimated $2.1M sold.
Macquarie Group first reported a position in AMN in Q1 2016 and held it in 29 quarters. The position peaked at $72.1M in Q4 2021. 426 funds tracked by Wall St. Rank hold AMN as of Q2 2023.
- Macquarie Group reported no remaining AMN Healthcare position as of Q2 2023 after selling out during the quarter.
- Macquarie Group sold 25,369 AMN Healthcare shares in Q2 2023, an estimated $2.1M.
- Macquarie Group first reported a position in AMN Healthcare in Q1 2016 and held it in 29 quarters.
- Macquarie Group's AMN Healthcare position peaked at $72.1M in Q4 2021.
- 426 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2023.
Based on Macquarie Group's 13F filing for Q2 2023, filed 14 Aug 2023.